Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Laurus Labs Shares Decline After Promoters Sell Stake Worth Rs 500 Crore

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Laurus Labs Shares Decline After Promoters Sell Stake Worth Rs 500 Crore

Analysed 16 Nov 2026·2 sources analysed·Visakhapatnam, India·Business
Laurus Labs Shares Decline After Promoters Sell Stake Worth Rs 500 CrorePreviousNext

Shares of pharmaceutical firm Laurus Labs fell between 3.5% and nearly 9% following promoters' sale of over 20 lakh shares worth around Rs 500 crore. Founder and CEO Satyanarayana Chava sold the majority stake, alongside other promoters. The stock had recently surged over 120% in one year, reaching a 52-week high. Laurus Labs reported a consolidated net profit of Rs 441 crore for Q2, driven by growth in CDMO and affordable medicine segments, and announced acquisitions to expand its market presence.

Sentiment
54%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (54/100). Lens Score 41/100.

Outlets measured: economictimes, moneycontrol. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 16 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (54/100)

Sentiment was consistent across outlets (52–55/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

moneycontrol broke this story on 16 Nov, 06:48 am. Other outlets followed.

16 Nov, 06:48 am2 sources · 2 h16 Nov, 09:03 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
L.T. Elevator Reports Rs 71.4 Crore Revenue and Rs 10.3 Crore Profit in H1 FY27
Next →
Belrise Industries Shares Rise Over 12% Following Strong Q2 FY27 Financial Results
1
moneycontrol16 Nov, 06:48 am
Laurus Labs shares fall 3.5 as promoters sell shares worth Rs 500 crore- Moneycontrol.com
  • 2
    economictimes16 Nov, 09:03 am
    Laurus Labs shares tumble nearly 9 after promoters sell stake worth Rs 500 crore; multibagger stock up 122 in one year
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Leven HoldingsLaurus LabsNSN HoldingsGalenvs ScienceSI & C Resins

    Story context

    Category
    Business
    Location
    Visakhapatnam, India
    Sources analysed
    2
    Last analysed
    16 Nov 2026
    Key entities
    Laurus LabsLakhCroreIndian rupeeNet incomeBiotechnologyChief executive officerPeptideChief financial officerDrug developmentManufacturingMedicine